What is IBI-Ag?
Established in 2017, IBI-Ag leverages breakthrough technology to produce efficient, selective, and safe bio-insect control solutions. Their approach utilizes environmentally friendly methods, focusing on the discovery and development of novel biological agents. The company's technology is designed to be highly cost-effective, particularly due to its suitability for fermentation processes, enabling farmers to produce agricultural produce at a lower cost. IBI-Ag aims to revolutionize pest management in agriculture through sustainable and advanced biological interventions.
How much funding has IBI-Ag raised?
IBI-Ag has raised a total of $16.1M across 2 funding rounds:
Other Financing Round
$6.1M
Series A
$10M
Other Financing Round (2025): $6.1M with participation from Corteva Agriscience and The Trendlines Group
Series A (2025): $10M led by Consensus Business Group, Corteva Agriscience, The Trendlines Group, and Iron Nation
Key Investors in IBI-Ag
Corteva Agriscience
Corteva Agriscience is a major player in the agriculture business, operating through Seed and Crop Protection segments. They focus on advanced germplasm, trait technologies, and digital solutions for farmers, as well as providing herbicides, insecticides, and other crop protection products. Their investment in IBI-Ag suggests a strategic interest in novel biological pest control solutions.
The Trendlines Group
The Trendlines Group is an investment company focused on inventing, discovering, and incubating innovation-based medtech and agrifood technologies. As hands-on investors, they are deeply involved in the development and business building of their portfolio companies, indicating a strategic alignment with IBI-Ag's mission to improve the human condition through agricultural innovation.
Consensus Business Group
Consensus Business Group is a UK-based investor primarily focused on residential ground rents. Their participation in IBI-Ag's funding round, alongside agricultural-focused entities, suggests a diversified investment strategy or a specific interest in the potential of IBI-Ag's technology within the broader agrifood sector.
What's next for IBI-Ag?
With the recent major strategic investment, IBI-Ag is poised to scale its operations and further its research and development in biological insect control. The substantial backing suggests a strong market validation for their innovative, environmentally conscious approach. This capital will likely be directed towards expanding production capabilities, enhancing their product pipeline, and broadening market reach. The company's focus on cost-effectiveness and farmer-centric solutions positions it for significant impact in the global agricultural sector, driving forward the adoption of sustainable pest management practices.
See full IBI-Ag company page
